Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Sep 2026. Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance…
Opportunity overview
- Project name
- Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)?
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Sep 2026. Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance…
Who is funding Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)?
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)?
The application deadline is 07 Sep 2026 00:00 (UTC).
Where will the Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.